La preservazione della fertilitàfemminile: aspettative e risultati

Size: px
Start display at page:

Download "La preservazione della fertilitàfemminile: aspettative e risultati"

Transcription

1 CLINICA VALLE GIULIA, Roma SALUS, Marostica (VI) GENERA Umbertide (PG) CLINICA RUESCH, Napoli La preservazione della fertilitàfemminile: aspettative e risultati Filippo Maria Ubaldi M.D. M.Sc. RISULTATI - crioconservazione ovocitaria - crioconservazione tessuto ovarico -uso di analoghi agonisti del GnRH ASPETTATIVE (attuali) - maturazione ovocitaria in vitro ASPETTATIVE (futuribili) -stemcells 1

2 Risultati-Crioconservazione Ovocitaria Congelamento ovocitario in Italia Registro Italiano PMA anno 2011, 19/7/2013 Ovociti Ovociti/Embrioni Oocyte (and embryo) cryopreservation is not performed in all Italian ART Centres (and in the vast majority of ART Centres in the world) 2

3 PRINCIPALE PREGIUDIZIO oocyte cryopreservation gives low pregnancy rates Validation of oocyte vitrification 2008: Efficiency in donation program not compromised with vitrification (Cobo, 2008; Nagy, 2008) Evidence based medicine 2008: The clinical pregnancy rate double with the introduction of vitrification (RCT) (Tulandi, 2008; Cao, 2009; Smith, 2010) 2010: Prospective randomized study with own sibling oocytes demonstrates the lab efficiency of the technique (RCT) (Rienzi, 2010) 2010: Cumulative ongoing pregnancy rate with oocyte vitrification in a standard infertility program (Ubaldi, 2010) 2010: Prospective randomized study with donor oocytes demonstrates clinical efficiency of the technique (RCT) (Cobo, 2011) 2011: Efficiency of oocytes vitrification in the infertile population (RCT) (Parmegiani, 2011) 2011: Meta-analysis of randomized controlled studies (Cobo 2011) 2012: Multicentric longitudinal cohort study to confirm reproducibility (Rienzi, 2012) 3

4 Oocyte vitrification: results Oocyte vitrification: results Centre 1: Centre 2: Centre 3: IVI Valencia GENERA Rome Mangiagalli Milan 462 oocyte warming cycles and ongoing pregnancy Infertility factor N MII N MII vitrified Sperm parameters Basal FSH Female age Incubation period Endometrial preparation Rienzi, et al., Hum Reprod

5 Oocyte vitrification: results Rienzi, et al., Hum Reprod 2012 Success rate depends on the age of the woman and on the number of vitrified oocytes MULTICENTRER STUDY GENERA, Rome IVI, Valencia University of Milan, Milan 46,4% 12,6% 2721 vitrified oocytes 147 new born Rienzi et al., Human Reproduction

6 Oocyte vitrification: cumulative pregnancy Oocyte vitrification: cumulative pregnancy 69/120 = 57,5% ongoing pregnancy rate Ubaldi, et al., Hum Reprod

7 Oocyte vitrification: cumulative pregnancy Ubaldi, et al., Hum Reprod 2010 Oocyte vs embryo vitrification: GENERA clinical results Oocyte vitri. presentence Fresh cycles 68/182 (37.4) I warming cycles II warming cycles 94/182 (51.6) 97/182 (53,3) Ubaldi 2010 Although a similar cumulative delivery rate was obtained, a significantly lower number of cycles per patient were performed in the post-sentence group when compared to the pre-sentence group (Mean number: 1.3 vs 1.6 respectively, p<0,05). Embryo vitri. postsentence 99/182 (54.4) 106/182 (58.2) 111/182 (60,1) Maggiulli, Ubaldi et al., oral presentation ESHRE Annual Meeting 2012 p <0.001 Ns Ns Warmed cycles clinical outcomes: GENERA (up to 42 y) Oocyte Warmed Cycle Embryo Warmed Cycle N of cycles N of patients Female Age (mean±sd) 36.4± ±3.8 Warmed Oocytes/Embryos Survival rate (%) N of ET (%) Transferred embryo (mean±sd) Clinical PR per Cycle (%) Clinical PR per ET (%) Implantation Rate Delivery Rate per warmed cycle (%) Delivery Rate per Embryo transfer (%) 1828/2064 (88.5) 437/503 (86.8) 1696/1746 (97.1) 900/919 (97.9) 2,10±0,8 1.86± /503 (26.0) 131/437 (29.9) 142/919 (15.4) 106/503 (21.0) 106/437 (24,2) 267/919 (29.0) 267/900 (29.7) 280/1680 (16.6) 231/919 (25.1) 231/900 (25,6) 7

8 Case Report (paziente oncologica) Age: 22 years (2008) 2006: Solid vascolarized cyst 103x70x80 mm right ovary and 26x30x20 mm left ovary. Ascitis. Laparoscopy: omentectomy, re-moval of both cysts - border line ovarian cancer 2008: Solid vascolarized cysts right and left ovary. Laparoscopy: removal of both cycsts border line ovarian cancer. Day3: FSH 12 mui/ml E2 255 pg/ml Ubaldi et al., Current Oncology 2014 In revisione 2008 Oocyte vitrification Flare-up protocol 300 IU FSH/die x 11 days 7 oocytes retrieved 6 MII vitrified (Kitazato) Jan 2013: Oocyte Warming cycle 4 oocytes survived 2 oocytes fertilized 1 embryo transferred (72h) Ongoing Clinical Pregancy Gestational Age: 37 weeks Oocyte vitrification in donors: results 8

9 Oocyte vitrification in oocyte donation: egg banking Oocyte vitrification and embryo aneuploidy 9

10 ASRM guideline ASRM guideline 10

11 Risultati-Crioconservazione tessuto ovarico Crypreservation and transplantation of ovarian tissue 11

12 Crypreservation and transplantation of ovarian tissue Pregnancies and outcome after ovarian tissue cryopreservation and transplantation. Ovarian cortex cryopreservation was initiated more than 15 years ago and performed with a view to either future reimplantationor follicular isolation and in vitro maturation (IVM) (Donnezand Bassil, 1998). IVM of follicles isolated from cryopreservedovarian cortex has not yet resulted in pregnancy, but the reimplantation technique has yielded pregnan ciesand live births (30 in about 15 years, Donnez, december2013) Most of patients undergoing ovarian cortex reimplantation have demonstrated restoration of ovarian function, experiencing follicular development and ovulation. Cryopreservation of ovarian tissue is the only fertility preservation option available for pre-pubertal girls and for women who cannot delay the start of chemotherapy Maltaris et al., 2009 Crypreservation and transplantation of ovarian tissue At present 30 healty babies have been born from frozen-thawed ovarian tissue grafting orthotopically. How much is the denumerator, 30/? Grynberg et al., 2012 Orthotopic transplantation allow to the resumption of menstrual cycle and to natural conception, with endocrinological function up to 2-5 y. 12

13 Crypreservation and transplantation of ovarian tissue Conclusion: VT offers similar conditions to fresh tissue for follicular density proliferation, viability, cell death and preserves a larger population of quiescent follicles than S.F. after transplantation, thus ensuring the maintenance of graft potential fertility Crypreservation and transplantation of ovarian tissue Conclusions: An approach using ovarian stimulation first, followed by laparoscopic collection of ovarian tissue, is a useful strategy for increasing the efficacy of fertility preservation techniques. The ovarian tissue is not affected by prior ovarian stimulation 13

14 Crypreservation and transplantation of ovarian tissue A strategic combination of approaches may maximize efficiency while avoiding any compromise to cancer treatment: ovarian tissue cryobanking with immature oocyte aspiration and IVM or ovarian stimulation and mature oocyte retrieval and ovarian tissue cyobanking Criopreservazione e trapianto di tessuto ovarico Controindicazioni al reimpianto di tessuto ovarico 14

15 Cryopreservation and transplantation of ovarian tissue in hematologic malignancy Risultati - Uso degli agonisti del GnRH 15

16 Uso degli agonisti del GnRH Uso degli agonisti del GnRH 16

17 Uso degli agonisti del GnRH 17

18 Uso degli agonisti del GnRH Aspettative Attuali - IVM 18

19 Aspettative Attuali - IVM Aspettative Attuali - IVM Donnez and Dolmans, Nature Reviews, dec

20 Aspettative Attuali - IVM Aspettative Attuali - IVM The development of follicles is regulated by a complex mixture of inhibitory and stimulatory endocrine, paracrine and autocrine signalling by the somatic cells (granulosa and surrounding theca cells) enhanced by a range of oocyte specific regulatory factors mediated through bidirectional communication within the follicle TELFER EE, MCLAUGHLIN M (2011) Semin Reprod Med 29(1):

21 Aspettative Futuribili Ovaio artificiale - Stem Cells Aspettative Attuali Ovaio artificiale For women diagnosed with leukemia, transplantation of cryopreserved ovarian tissue after disease remission is not advisable. Therefore, to restore fertility in these patients, we aim to develop a biodegradable artificial ovary that offers an environment where isolated follicles and ovarian cells (OCs) can survive and grow. After transplantation, this matrix was able to degrade, allowed vascularization and elicited a low inflammatory response. 21

22 Aspettative Futuribili - Stem Cells Le ovaie contengono un pool di follicoli predeterminato durante la vita fetale e mai piu rinnovabile Dimostrata l esistenza di OSC oogonial stem cells aventi la capacità di mantenere la produzione di ovociti e follicoli anche dopo la nascita con concentrazione decrescente in base alla età Johnson, J. et al. Nature 428, (2004) White, Y. A. R. et al. Nature Med. 18, (2012) Aspettative Futuribili - Stem Cells 2012, 98 (1): , 98 (1):

23 Aspettative Futuribili - Stem Cells Stem Cells - eventuali applicazioni 23

24 The future: making oocytes from germ line stem cells? Development of culture systems that support human oocyte development MAY WELL OFFER practical solutions to fertility preservation for many women for whom conventional methods cannot be used but there is stillalong WAY TO GO before all the relevant testing can be carried out Grazie per l attenzione 24

25 CLINICA VALLE GIULIA, Roma SALUS, Marostica (VI) GENERA Umbertide (PG) GENERA RUESCH, Napoli Ginecologia: Filippo Ubaldi Antonio Angelini Laura Buffo Antonio Ciconte Silvia Colamaria Fabrizio Fiorini A. Giallonardo Maddalena Giuliani Enrica Gravotta Fabio Sapienza Mauro Schimberni Silvia Venanzi Embriologia: Laura Rienzi Stefania Romano Roberta Maggiulli Laura Albricci Antonio Capalbo Nicoletta Barnocchi Benedetta Iussig Danilo Cimadomo Federica Sanges Catello Scarica Elena Ievoli Marta Stoppa Ludovica Dusi Letizia Papini Lisa Dovere Aspettative: attuali future Competenza ovocitaria Gametogenesi in vitro Gametogenesi in vivo Coltura da cortex ovarica Gameti artificiali IVG-IVM SCNT hesc ips 25

THE NEW ERA OF PGS APPLICATION IN ART

THE NEW ERA OF PGS APPLICATION IN ART GENERA and BIOROMA Symposium 2015 THE NEW ERA OF PGS APPLICATION IN ART 13 14 February 2015 Rome Roma Eventi Piazza di Spagna Via Alibert, 5 Welcome to all This GENERA and Bioroma Symposium is aimed at

More information

Fertility Preservation in Women with Cancer. Objectives. Patient #1 10/24/2011. The audience will understand: How cancer therapy affects fertility.

Fertility Preservation in Women with Cancer. Objectives. Patient #1 10/24/2011. The audience will understand: How cancer therapy affects fertility. Fertility Preservation in Women with Cancer Leslie R. DeMars Dartmouth-Hitchcock Medical Center Objectives The audience will understand: How cancer therapy affects fertility. Who should be considered for

More information

Fertility care for women diagnosed with cancer

Fertility care for women diagnosed with cancer Saint Mary s Hospital Department of Reproductive Medicine Fertility care for women diagnosed with cancer Information For Patients INF/DRM/NUR/16 V1/01/11/2013 1 2 Contents Page Overview 4 Our Service 4

More information

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2

Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2 August 2012 content 8 Preimplantation genetic diagnosis new method of screening of 24 chromosomes with the Array CGH method...2 Maintaining fertility new opportunities in GENNET...3 Hysteroscopy without

More information

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com

AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Page 1 of 6 AGE & FERTILITY: Effective Evaluation & Treatment I. LANE WONG, MD, FACOG. www.hopefertilitycenter.com www.hopeivf.com Age has a profound effect on female fertility. This is common knowledge,

More information

A POWERFUL IN VITRO FERTILIZATION

A POWERFUL IN VITRO FERTILIZATION A POWERFUL During the past 50 years technological advances in the field of bovine reproduction have led to some dramatic changes in the way cattle look, reproduce, perform, and even taste. Artificial Insemination

More information

Management fertility sparing degli endometriomi Errico Zupi

Management fertility sparing degli endometriomi Errico Zupi Management fertility sparing degli endometriomi Errico Zupi Università Tor Vergata Roma Management of endometrioma Pain Infertility Surgical treatment Medical treatment Infertility clinic Both medical

More information

In vitro development of human ovarian follicles. Evelyn E Telfer Institute of Cell Biology University of Edinburgh

In vitro development of human ovarian follicles. Evelyn E Telfer Institute of Cell Biology University of Edinburgh In vitro development of human ovarian follicles Evelyn E Telfer Institute of Cell Biology University of Edinburgh Fertility preservation options Embryo Freezing Oocyte Freezing (hormonal stimulation) Immature

More information

Community Hospital North. Clearvista Dr.

Community Hospital North. Clearvista Dr. 100% IVF Refund Program Community Hospital North Clearvista Dr. N Dr. David Carnovale and Dr. Jeffrey Boldt, along with everyone at Community Reproductive Endocrinology, are committed to providing you

More information

ASSISTED REPRODUCTIVE TECHNOLOGY (ART)

ASSISTED REPRODUCTIVE TECHNOLOGY (ART) ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian Hospital ARTS program. This document provides an overview of treatment protocols and more specific instructions

More information

IN VITRO FERTILIZATION (IVF) INFORMATION PACKAGE Form # CFRH -102 (13-Dec-2013)

IN VITRO FERTILIZATION (IVF) INFORMATION PACKAGE Form # CFRH -102 (13-Dec-2013) Centre for Fertility & Reproductive Health 250 Dundas St W., Suite 700 Toronto, ON M5T 2Z5 tel: 416-586-4748; fax: 416-586-4686 IN VITRO FERTILIZATION (IVF) INFORMATION PACKAGE Form # CFRH -102 (13-Dec-2013)

More information

IN VITRO FERTILISATION (IVF) & INTRACYTOPLASMIC SPERM INJECTION (ICSI) INCLUDING FREEZING OF EMBRYOS CONSENT FORM

IN VITRO FERTILISATION (IVF) & INTRACYTOPLASMIC SPERM INJECTION (ICSI) INCLUDING FREEZING OF EMBRYOS CONSENT FORM IN VITRO FERTILISATION (IVF) & INTRACYTOPLASMIC SPERM INJECTION (ICSI) INCLUDING FREEZING OF EMBRYOS CONSENT FORM Patient Name... DOB... Partner Name (if applicable)...dob... Patient Number... I/ We request

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment

More information

INFERTILITY FOR THE PRIMARY CARE PROVIDER

INFERTILITY FOR THE PRIMARY CARE PROVIDER INFERTILITY FOR THE PRIMARY CARE PROVIDER Top Ten Myths Kristen E. Cain, MD FACOG Reproductive Medicine Institute Sanford Health, Fargo, ND NOTHING TO DISCLOSE The top ten myths Educational Objectives

More information

Ovarian stimulation for fertility preservation. Juan A García Velasco IVI-Madrid

Ovarian stimulation for fertility preservation. Juan A García Velasco IVI-Madrid Ovarian stimulation for fertility preservation Juan A García Velasco IVI-Madrid Outline To whom are we offering treatment What do we do How do we do it Results Outline To whom are we offering treatment

More information

Understand the risks, explore your options and plan for your future.

Understand the risks, explore your options and plan for your future. Understand the risks, explore your options and plan for your future. 1 Table of Contents Introduction MEN Fertility Risks 3 Fertility Preservation Options 4 Possible Fertility Outcomes 4 Parenthood Options

More information

Fertility and Women With Cancer

Fertility and Women With Cancer Fertility and Women With Cancer Although not everyone ends up having children, most people want to at least have the option. Cancer and treatment for cancer can sometimes make this harder or even take

More information

The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells

The Menstrual Cycle. Model 1: Ovarian Cycle follicular cells The Menstrual Cycle REVIEW questions to complete before starting this POGIL activity 1. Gonads produce both gametes and sex steroid hormones. For the female, name the: A. gonads ovaries B. gametes oocyte/ovum/egg

More information

Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent

Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent Book Number Patient Name (Please print): Patient, IVFNE

More information

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups

Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups Infertility Services Medical Policy For University of Vermont Medical Center and Central Vermont Medical Center employer groups File name: Infertility Services File code: UM.REPRO.01 Last Review: 02/2016

More information

Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent

Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent Assisted Reproduction: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Consent Book Number Patient Name (Please print): Patient, IVFNE

More information

Fertility Treatment - Glossary

Fertility Treatment - Glossary {loadpositionaddthis} Fertility Treatment - Glossary Adoption: The legal process in which a couple adopt parents. a child and become its legal Annovulatory: Absence of ovulation. Antral Follicles: Smaller

More information

Assisted reproductive technology in Australia and New Zealand National Perinatal Epidemiology and Statistics Unit

Assisted reproductive technology in Australia and New Zealand National Perinatal Epidemiology and Statistics Unit Assisted reproductive technology in Australia and New Zealand 2013 Never Stand Still Medicine National Perinatal Epidemiology and Statistics Unit Assisted reproductive technology in Australia and New Zealand

More information

Endometrioma : what is the best option? Claudia Tosti, Errico Zupi

Endometrioma : what is the best option? Claudia Tosti, Errico Zupi Endometrioma : what is the best option? Claudia Tosti, Errico Zupi Clinical symptoms Endometrioma Deep endometriosis Adenomyosis Ovarian reserve Bilateral endometrioma Previous surgery American Society

More information

Assisted reproductive technology in Australia and New Zealand 2010

Assisted reproductive technology in Australia and New Zealand 2010 Assisted reproductive technology in Australia and New Zealand 2010 ASSISTED REPRODUCTION SERIES Number 16 Assisted reproductive technology in Australia and New Zealand 2010 Alan Macaldowie Yueping A Wang

More information

The Olive BRA NCH Fertility unit PATIENT INFORMATION SERIES

The Olive BRA NCH Fertility unit PATIENT INFORMATION SERIES The Olive BRA NCH Fertility unit PATIENT INFORMATION SERIES What you need to know about IVF/ICSI- ET? The following information explains briefly the procedures of In Vitro Fertilisation (IVF/ICSI). This

More information

Controversy: Is IVF Associated with Increased Rate of Birth Defect

Controversy: Is IVF Associated with Increased Rate of Birth Defect Controversy: Is IVF Associated with Increased Rate of Birth Defect R 5 謝佳琳 In Vitro Fertilization as Associated with an Increase in Major Birth Defects Christine K. Olson, M.D Division of Reproductive

More information

IVF OVERVIEW. Tracy Telles, M.D.

IVF OVERVIEW. Tracy Telles, M.D. IVF OVERVIEW By Tracy Telles, M.D. Dr. Hendler: Hello and welcome to KP Healthcast. I m your host Dr. Peter Hendler and today our guest is Dr. Tracy Telles. Dr. Telles is an IVF physician in Kaiser Walnut

More information

Center for Women s Reproductive Care at Columbia University

Center for Women s Reproductive Care at Columbia University Center for Women s Reproductive Care at Columbia University Oocyte Recipients Greetings, Thank you for your interest in the Center for Women s Reproductive Care at Columbia University. We hope that the

More information

Menstrual Cycle. Ovarian Cycle

Menstrual Cycle. Ovarian Cycle Menstrual Cycle 2 cycles: Ovarian & Uterine Controlled by hormonal changes Ovarian Cycle Average ovarian cycle lasts 28 days Normally interrupted only by pregnancy Finally terminated by menopause Two alternating

More information

Assignment Discovery Online Curriculum

Assignment Discovery Online Curriculum Assignment Discovery Online Curriculum Lesson title: In Vitro Fertilization Grade level: 9-12, with adaptation for younger students Subject area: Life Science Duration: Two class periods Objectives: Students

More information

Fertility Research Policy

Fertility Research Policy Fertility Research Policy Rationale and Objective Merck Serono has a strong commitment to deliver innovations in Fertility treatments to help infertile couples achieve their desire to have a baby. Innovations

More information

Overview for IVF Patients Introduction

Overview for IVF Patients Introduction 810 Chafee Avenue Augusta, GA 30904 Phone: 706-722-4434 Fax: 706-722-9647 Overview for IVF Patients Introduction 618 Ponder Place Evans, GA 30809 Phone: 706-722-4434 Fax: 706-722-9647 In vitro fertilization

More information

Assisted Reproductive Technologies at IGO

Assisted Reproductive Technologies at IGO 9339 Genesee Avenue, Suite 220 San Diego, CA 92121 858 455 7520 Assisted Reproductive Technologies at IGO Although IGO no longer operates an IVF laboratory or program as such, we work closely with area

More information

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile?

FERTILITY AND AGE. Introduction. Fertility in the later 30's and 40's. Am I fertile? FERTILITY AND AGE Introduction Delaying pregnancy is a common choice for women in today's society. The number of women in their late 30s and 40s attempting pregnancy and having babies has increased in

More information

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050

REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 REPRODUCTIVE MEDICINE AND INFERTILITY ASSOCIATES Woodbury Medical Arts Building 2101 Woodwinds Drive Woodbury, MN 55125 (651) 222-6050 RECIPIENT COUPLE INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION

More information

Reproduction and its Hormonal Control

Reproduction and its Hormonal Control Reproduction and its Hormonal Control Page 1 Reproduction and its Hormonal Control Different mammals have different patterns of reproduction Eg mammals, rats and mice can breed all year round, whereas

More information

European IVF Monitoring (EIM) Year: 2008

European IVF Monitoring (EIM) Year: 2008 European IVF Monitoring (EIM) Year: 2008 Name of country POLAND Name and full address of contact person. professor Rafal Kurzawa MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological

More information

Ontwikkelingen en regelgeving rond het invriezen van eicellen. Centrum voor Voortplantingsgeneekunde Vrouwenkliniek AMC (f.mol@amc.

Ontwikkelingen en regelgeving rond het invriezen van eicellen. Centrum voor Voortplantingsgeneekunde Vrouwenkliniek AMC (f.mol@amc. Ontwikkelingen en regelgeving rond het invriezen van eicellen Femke Mol,, Mariette Goddijn, Fulco van der Veen, Annemiek de Melker, Sjoerd Repping, Centrum voor Voortplantingsgeneekunde Vrouwenkliniek

More information

09 LC 37 0857 A BILL TO BE ENTITLED AN ACT

09 LC 37 0857 A BILL TO BE ENTITLED AN ACT Senate Bill 169 By: Senators Hudgens of the 47th, Williams of the 19th, Rogers of the 21st, Thomas of the 54th, Shafer of the 48th and others A BILL TO BE ENTITLED AN ACT 1 To amend Chapter 7 of Title

More information

Welcome to chapter 8. The following chapter is called "Monitoring IVF Cycle & Oocyte Retrieval". The author is Professor Jie Qiao.

Welcome to chapter 8. The following chapter is called Monitoring IVF Cycle & Oocyte Retrieval. The author is Professor Jie Qiao. Welcome to chapter 8. The following chapter is called "Monitoring IVF Cycle & Oocyte Retrieval". The author is Professor Jie Qiao. The learning objectives of this chapter are 2 fold. The first section

More information

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance.

Authorized By: Holly C. Bakke, Commissioner, Department of Banking and Insurance. INSURANCE DIVISION OF INSURANCE Actuarial Services Benefit Standards for Infertility Coverage Proposed New Rules: N.J.A.C. 11:4-54 Authorized By: Holly C. Bakke, Commissioner, Department of Banking and

More information

Supplementation of culture media. multiple unsuccessful IVF attempts: a new indication for EmbryoGen?

Supplementation of culture media. multiple unsuccessful IVF attempts: a new indication for EmbryoGen? Supplementation of culture media with GM-CSF in patients with multiple unsuccessful IVF attempts: a new indication for EmbryoGen? Ioannis Sfontouris, M.Med.Sci., PhD Head of Embryology, Eugonia Assisted

More information

MODEL FORM. [Program s SART Name and Number] INFORMED CONSENT FOR EGG DONORS

MODEL FORM. [Program s SART Name and Number] INFORMED CONSENT FOR EGG DONORS MODEL FORM [Program s SART Name and Number] INFORMED CONSENT FOR EGG DONORS You are agreeing to undergo a cycle of egg donation at [program s SART name]. Do not sign this document if you have not received

More information

Development of Personalised Infertility Treatment Robust Collaboration Between Drug and Diagnostic Developers

Development of Personalised Infertility Treatment Robust Collaboration Between Drug and Diagnostic Developers Development of Personalised Infertility Treatment Robust Collaboration Between Drug and Diagnostic Developers Joan-Carles Arce, MD PhD Vice President, Science & Medicine, Reproductive Health Global Non-Clinical

More information

FERTILITY PRESERVATION PROGRAM

FERTILITY PRESERVATION PROGRAM FERTILITY PRESERVATION PROGRAM The University of Illinois Fertility Preservation Program offers a comprehensive team approach to help women faced with serious conditions which may impair future fertility.

More information

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014

East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception. December 2014 East and North Hertfordshire CCG Fertility treatment and referral criteria for tertiary level assisted conception December 2014 1 1. Introduction This policy sets out the entitlement and service that will

More information

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES

INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES INFORMED CONSENT AND AUTHORIZATION FOR IN VITRO FERTILIZATION OF PREVIOUSLY CRYOPRESERVED OOCYTES We, the undersigned, as patient and partner understand that we will be undergoing one or more procedures

More information

THE PRESENT AND THE FUTURE OF FERTILITY PRESERVATION

THE PRESENT AND THE FUTURE OF FERTILITY PRESERVATION International Society for Fertility Preservation FONDAZIONE PER GLISTUDI SULLA RIPRODUZIONE UMANA November 2 nd 2012 Hands-on: Gamete and Tissue Cryopreservation Venue:Clinica Candela Hands-on: Natural

More information

Assisted reproductive technology in Australia and New Zealand 2012

Assisted reproductive technology in Australia and New Zealand 2012 Assisted reproductive technology in Australia and New Zealand 2012 In 2012, there were 70,082 assisted reproductive technology (ART) treatment cycles performed in Australian and New Zealand. Of these,

More information

FACTS. No. 23 in a series providing the latest information for patients, caregivers and healthcare professionals

FACTS. No. 23 in a series providing the latest information for patients, caregivers and healthcare professionals LEUKEMIA LYMPHOMA MYELOMA FACTS Fertility No. 23 in a series providing the latest information for patients, caregivers and healthcare professionals Highlights The term fertility is used to describe the

More information

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART)

ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) ASSISTED REPRODUCTIVE TECHNOLOGIES (ART) Dr. Herve Lucas, MD, PhD, Biologist, Andrologist Dr. Taher Elbarbary, MD Gynecologist-Obstetrician Definitions of Assisted Reproductive Technologies Techniques

More information

Endometriosis will not Lower IVF Success

Endometriosis will not Lower IVF Success Endometriosis will not Lower IVF Success Endometriosis will not Lower IVF Success Effects of endometriosis on fertility treatment success has always been a controversy. When a woman is diagnosed with endometriosis,

More information

Artificial insemination with donor sperm

Artificial insemination with donor sperm Artificial insemination with donor sperm Ref. 123 / 2009 Reproductive Medicine Unit Servicio de Medicina de la Reproducción Gran Vía Carlos III 71-75 08028 Barcelona Tel. (+34) 93 227 47 00 Fax. (+34)

More information

ORAL CONTRACEPTIVES prior to IVF. Clinical center of Vojvodina, Department of Human reproduction Prof. dr sc.med Aleksandra Trninić Pjević

ORAL CONTRACEPTIVES prior to IVF. Clinical center of Vojvodina, Department of Human reproduction Prof. dr sc.med Aleksandra Trninić Pjević ORAL CONTRACEPTIVES prior to IVF Clinical center of Vojvodina, Department of Human reproduction Prof. dr sc.med Aleksandra Trninić Pjević Paradox Treating subfertile patients with a medicine that is mainly

More information

Laboratoires Genevirer Menotrophin LG IU 1.8.2

Laboratoires Genevirer Menotrophin LG IU 1.8.2 Menotrophin LG 75-50 IU.8.2 VI.2 VI.2. Elements for a Public Summary Overview of disease epidemiology Infertility is when a woman cannot get pregnant (conceive) despite having regular unprotected sexual

More information

European IVF Monitoring (EIM) Year: 2010

European IVF Monitoring (EIM) Year: 2010 European IVF Monitoring (EIM) Year: 2010 Name of country: Poland Name and full address of contact person: Professor Rafal Kurzawa, MD PhD Fertility and Sterility Special Interest Group Polish Gynaecological

More information

Counselling Session for IVF/ET patients

Counselling Session for IVF/ET patients Page Page 1 of 9 Counselling Session for IVF/ET patients 1. Please attend the following counselling session. Place: Seminar Room, Room 509, 5/F, Block K, Queen Mary Hospital Lecture Theatre, Room 602,

More information

December 4, 2014 Rebecca Johnson, MD Mary Bridge Hospital Tacoma, WA USA

December 4, 2014 Rebecca Johnson, MD Mary Bridge Hospital Tacoma, WA USA Fertility preservation for AYAs December 4, 2014 Rebecca Johnson, MD Mary Bridge Hospital Tacoma, WA USA Aims Guidelines Barriers to implementation Assessment of risk Methods of preserving fertility Optimising

More information

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS)

Consent to Perform Preimplantation Genetic Screening (PGS) using. Comparative Genomic Hybridization (acgh) or Next Generation Sequencing (NGS) Consent to Perform Preimplantation Genetic Screening (PGS) using Array Comparative Genomic Hybridization (acgh ) or Next Generation Sequencing (NGS) Purpose The purpose of Preimplantation Genetic Screening

More information

Fertility-related choices. A decision aid for younger women with early breast cancer

Fertility-related choices. A decision aid for younger women with early breast cancer Fertility-related choices A decision aid for younger women with early breast cancer Fertility-related choices Section 1 About this booklet 1 Overview 3 Summary of fertility options 4 Section 2 Some background

More information

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY

COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY COVENTRY HEALTH CARE OF ILLINOIS, INC. COVENTRY HEALTH CARE OF MISSOURI, INC. Medical Management Policy and Procedure PROPRIETARY Policy: Infertility Evaluation and Treatment Number: MM 1306 Date Effective:

More information

Premier Health Plan POLICY AND PROCEDURE MANUAL

Premier Health Plan POLICY AND PROCEDURE MANUAL Premier Health Plan POLICY AND PROCEDURE MANUAL MP.018.PH - Infertility- Treatment This policy applies to the following lines of business: Premier Commercial Premier Employee Premier Health Plan considers

More information

Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc., M.D.

Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc., M.D. Role of luteinizing hormone supplementation in the follicular phase and pregnancy, during controlled ovarian hyperstimulation in in vitro fertilization Systematic review by: Dr. Ashraf Ahmed ElDaly, M.Sc.,

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. In vitro fertilisation treatment for people with fertility problems bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be

More information

IVF : ; ; ; : R714.13 : A : 0253-357X(2015)03-0196-05 IVF, IVF, IVF, 5%~15% [1-4], IVF, >60% IVF, IVF ICSI , IVF IVF,

IVF : ; ; ; : R714.13 : A : 0253-357X(2015)03-0196-05 IVF, IVF, IVF, 5%~15% [1-4], IVF, >60% IVF, IVF ICSI , IVF IVF, 35 3 Vol.35 No.3 2015 3 Mar. 2015 Reproduction & Contraception doi: 10.7669/j.issn.0253-357X.2015.03.0196 E-mail: randc_journal@163.com ( 518036) : - (-ET) : >60% (n=153) (n=180) : 1 619 1 986 133 152

More information

Ethical issues in assisted reproductive technologies. Effy Vayena

Ethical issues in assisted reproductive technologies. Effy Vayena Ethical issues in assisted reproductive technologies Effy Vayena Assisted Reproductive Technologies (ART) All treatments or procedures that include the in vitro handling of human oocytes and human sperm

More information

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register

Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register 1 Assisted reproductive technologies (ART) in Canada: 2011 results from the Canadian ART Register Joanne Gunby, M.Sc. CARTR Co-ordinator Email: gunbyj@mcmaster.ca Supported by the IVF Directors Group of

More information

SPONTANEOUS AND PHARMACOLOGICALLY INDUCED REMISSIONS IN PATIENTS WITH PREMATURE OVARIAN FAILURE

SPONTANEOUS AND PHARMACOLOGICALLY INDUCED REMISSIONS IN PATIENTS WITH PREMATURE OVARIAN FAILURE SPONTANEOUS AND PHARMACOLOGICALLY INDUCED REMISSIONS IN PATIENTS WITH PREMATURE OVARIAN FAILURE David Kreiner, M. D. * Kathleen Droesch, M.D. Daniel Navot, M.D. Richard Scott, M.D. Zev Rosenwaks, M.D.

More information

Areas of Concern. Reproductive Ethics: Issues &

Areas of Concern. Reproductive Ethics: Issues & Reproductive Ethics: Issues & Areas of Concern Conception Control: under what conditions is conception control in harmony with a Christian ethic? Genetic Screening & Counseling: under what conditions should

More information

SO, WHAT IS A POOR RESPONDER?

SO, WHAT IS A POOR RESPONDER? SO, WHAT IS A POOR RESPONDER? We now understand why ovarian reserve is important and how we assess it, but how is poor response defined? Unfortunately, there is no universally accepted definition for the

More information

Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc

Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc Act of 5 December 2003 No. 100 relating to the application of biotechnology in human medicine, etc Cf. earlier Acts of 5 August 1994 No. 56 and 12 June 1987 No. 68 Chapter 1. Purpose and scope 1-1. Purpose

More information

The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test".

The following chapter is called Follow-ups with a Positive or a Negative Pregnancy Test. Slide 1 Welcome to chapter 7. The following chapter is called "Follow-ups with a Positive or a Negative Pregnancy Test". The author is Professor Pasquale Patrizio. Slide 2 This chapter has the following

More information

Page 1. 1. The production of monoploid cells by spermatogenesis occurs in (1) zygotes (3) ovaries (2) testes (4) meristems

Page 1. 1. The production of monoploid cells by spermatogenesis occurs in (1) zygotes (3) ovaries (2) testes (4) meristems 1. The production of monoploid cells by spermatogenesis occurs in (1) zygotes (3) ovaries (2) testes (4) meristems Base your answers to questions 2 and 3 on the diagram below of the female reproductive

More information

Fertility and breast cancer treatment

Fertility and breast cancer treatment Fertility and breast cancer treatment This booklet is about breast cancer treatment and fertility. It describes how treatment for primary breast cancer may affect a woman s fertility and possible ways

More information

Fertility Facts and Figures 2008

Fertility Facts and Figures 2008 Fertility Facts and Figures 2008 Contents About these statistics... 2 Accessing our data... 2 The scale of fertility problems... 3 Treatment abroad... 3 Contacts regarding this publication... 3 Latest

More information

My Sister s s Keeper. Science Background Talk

My Sister s s Keeper. Science Background Talk My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating

More information

Egg Donation Process, Risks, Consent and Agreement

Egg Donation Process, Risks, Consent and Agreement THE CENTER FOR HUMAN REPRODUCTION (CHR) 21 East 69 th Street, New York, NY 10021 T: 212-994-4400; F: 212-994-4499 Egg Donation Process, Risks, Consent and Agreement Updated on: 10/8/2014 Date: Egg Donor

More information

IVF. IVF: The Success of Technology. Recent Advances in Assisted Reproductive Technologies 10/20/2007

IVF. IVF: The Success of Technology. Recent Advances in Assisted Reproductive Technologies 10/20/2007 Obstetrics and Gynecology Update: What Does the Evidence Tell Us? 1 In Vitro Fertilization () 2 Recent Advances in Assisted Reproductive Technologies Shehua Shen, M.D., ELD (ABB) Assistant Professor Department

More information

Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES

Age and Fertility. A Guide for Patients PATIENT INFORMATION SERIES Age and Fertility A Guide for Patients PATIENT INFORMATION SERIES Published by the American Society for Reproductive Medicine under the direction of the Patient Education Committee and the Publications

More information

Ovarian Cyst. Homoeopathy Clinic. Introduction. Types of Ovarian Cysts. Contents. Case Reports. 21 August 2002

Ovarian Cyst. Homoeopathy Clinic. Introduction. Types of Ovarian Cysts. Contents. Case Reports. 21 August 2002 Case Reports 21 August 2002 Ovarian Cyst Homoeopathy Clinic Check Yourself If you have any of the following symptoms call your doctor. Sense of fullness or pressure or a dull ache in the abdomen Pain during

More information

Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system.

Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system. Ovarian Cysts Introduction Ovarian cysts are a very common female condition. An ovarian cyst is a fluid-filled sac on an ovary in the female reproductive system. Most women have ovarian cysts sometime

More information

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY

Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Symposium on RECENT ADVANCES IN ASSISTED REPRODUCTIVE TECHNOLOGY Dr Niel Senewirathne Senior Consultant of Obstetrician & Gynaecologist De zoyza Maternity Hospita 1 ART - IVF & ICSI 2 Infertility No pregnancy

More information

Lesbian Pregnancy: Donor Insemination

Lesbian Pregnancy: Donor Insemination Lesbian Pregnancy: Donor Insemination (Based on an article originally published in the American Fertility Association 2010 National Fertility and Adoption Directory. Much of this information will also

More information

A BEGINNER S GUIDE TO TESTING YOUR FERTILITY WHAT YOU SHOULD KNOW BEFORE EGG FREEZING

A BEGINNER S GUIDE TO TESTING YOUR FERTILITY WHAT YOU SHOULD KNOW BEFORE EGG FREEZING A BEGINNER S GUIDE TO TESTING YOUR FERTILITY WHAT YOU SHOULD KNOW BEFORE EGG FREEZING Should I freeze my eggs? Amazing to think that this question, which couldn t even have been considered a few short

More information

The following chapter is called Ovulation Induction in the Polycystic Ovary.

The following chapter is called Ovulation Induction in the Polycystic Ovary. Welcome to chapter 5. The following chapter is called Ovulation Induction in the Polycystic Ovary. The author is Dr. Ernesto Bosch. ALT: Please use the navigation bar at the bottom of the viewing panel

More information

X-Sheet 14. Gametogenesis and Hormone Control. Life Sciences X-Sheets

X-Sheet 14. Gametogenesis and Hormone Control. Life Sciences X-Sheets X-Sheet 14 Gametogenesis and Hormone Control 109 Key Concepts Reproduction takes place as three processes: Gametogenesis production of the gametes (in Males = Spermatogenesis and in females = Oogenesis)

More information

Ovarian endometrioma: guidelines for selection of cases for surgical treatment or expectant management

Ovarian endometrioma: guidelines for selection of cases for surgical treatment or expectant management Review Ovarian endometrioma: guidelines for selection of cases for surgical treatment or expectant management Expert Rev. Obstet. Gynecol. 8(1), 29 55 (2013) Molly Carnahan, Jennifer Fedor, Ashok Agarwal

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT FOR IN VITRO FERTILIZATION AND EMBRYO TRANSFER Partner #1 Last Name (Surname): Partner #1 First Name: Partner #1 Last 5 Digits

More information

East Midlands CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services

East Midlands CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services East Midlands CCGs Commissioning Policy for In Vitro Fertilisation (IVF)/ Intracytoplasmic Sperm Injection (ICSI) within tertiary Infertility Services November 2013 Reference Number: CG023 Version: 5.0

More information

LAB. STAGES OF THE HUMAN MENSTRUAL CYCLE

LAB. STAGES OF THE HUMAN MENSTRUAL CYCLE Period Date LAB. STAGES OF THE HUMAN MENSTRUAL CYCLE When a human female is born, her ovaries already contain all the immature eggs that will later mature and produce functional eggs during her lifetime.

More information

Dr.M.Aliyari. Sahand Medical Laboratory. IVF Stimulation protocols

Dr.M.Aliyari. Sahand Medical Laboratory. IVF Stimulation protocols IVF Stimulation protocols IVF protocols Natural Cycle IVF In 1978 the first successful IVF procedure was performed without the use of drugs. This technique was abandoned due to low success rates in subsequent

More information

Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART)

Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART) Biology and Society Unit Five: Human Reproduction Topic Four: Assisted Reproductive Technologies (ART) Carl Djerassi (1923 - ) Excerpt from Sex in an Age of Mechanical Reproduction by Carl Djerassi With

More information

Ehlers-Danlos Syndrome Fertility Issues. Objectives

Ehlers-Danlos Syndrome Fertility Issues. Objectives Ehlers-Danlos Syndrome Fertility Issues Baltimore Inner Harbor Independence Day Brad Hurst, M.D. Professor Reproductive Endocrinology Carolinas Medical Center - Charlotte, North Carolina Objectives Determine

More information

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy

Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy Final Version Two (Sept 2014) Eastern Cheshire Clinical Commissioning Group NHS Funded Treatment for Subfertility Policy NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA Table of Contents 1.

More information

Endocrinology of the Female Reproductive Axis

Endocrinology of the Female Reproductive Axis Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN

More information

Endometriosis, Fertility and Pregnancy

Endometriosis, Fertility and Pregnancy This leaflet covers endometriosis and fertility. It provides information for women who have been diagnosed with endometriosis who would like to know if and how this can affect their fertility, and for

More information

Reproductive Technology. Chapter 21

Reproductive Technology. Chapter 21 Reproductive Technology Chapter 21 Assisted Reproduction When a couple is sub-fertile or infertile they may need Assisted Reproduction to become pregnant: Replace source of gametes Sperm, oocyte or zygote

More information

In Vitro Fertilization

In Vitro Fertilization Patient Education In Vitro Fertilization What to expect This handout describes how to prepare for and what to expect when you have in vitro fertilization. It provides written information about this process,

More information

In - Vitro Fertilization Handbook

In - Vitro Fertilization Handbook In - Vitro Fertilization Handbook William F. Ziegler, D.O. Medical Director Scott Kratka, ELD, TS Embryology Laboratory Director Lauren F. Lucas, P.A.-C, M.S. Physician Assistant Frances Cerniak, R.N.

More information